Literature DB >> 25428965

Draft Genome Sequence of an International Clonal Lineage 1 Acinetobacter baumannii Strain from Argentina.

Elisabet Vilacoba1, Maxime Déraspe2, German M Traglia1, Paul H Roy2, María Soledad Ramírez3, Daniela Centrón1.   

Abstract

In the last few years Acinetobacter baumannii has emerged worldwide as an important nosocomial pathogen in medical institutions. Here, we present the draft genome sequence of the international clonal lineage 1 (ICL1) A. baumannii strain A144 that was isolated in a hospital in Buenos Aires City in the year 1997. The strain is susceptible to carbapenems and resistant to trimethoprim and gentamicin.
Copyright © 2014 Vilacoba et al.

Entities:  

Year:  2014        PMID: 25428965      PMCID: PMC4246157          DOI: 10.1128/genomeA.01190-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii often causes infections in hospitalized patients, being one of the major causes of ventilator-associated pneumonia (1–3). Extreme levels of resistance, including resistance to carbapenems, tigecycline, and also colistin, has dramatically increased in the past years (4, 5). In Argentina, A. baumannii has been a worrisome problem since the late 1990s, when numerous outbreaks caused by this microorganism occurred in clinical settings, in particular in intensive care units (6). To date, there are only two whole-genome sequences of A. baumannii strains isolated in Argentina available in GenBank. One of them corresponds to the naturally competent A. baumannii strain A118 and the other to a recently extensively drug-resistant A. baumannii indigo-pigmented strain A33405 (7, 8). Here, we announce the draft genome sequences of A. baumannii 144, which was isolated in 1997, when carbapenems were introduced into our clinical settings. The multilocus sequence typing technique classified A. baumannii 144 as international clonal lineage 1 (ICL1), which is not the predominant clonal lineage disseminated in Argentina (9). Whole-genome shotgun sequencing was performed using Illumina MiSeq- I, using Nextera XT libraries for sample preparation. Reads were assembled with the Ray assembler (http://denovoassembler.sourceforge.net). The draft genome sequence of A144 consists of 92 contigs (length >500 bp), a total sequence of 4,312,914 bp with an N50 contig size of 89,819. The GC% average was 39.2. Using the RAST server to detect coding regions, we identified 4,151 possible ORFs. There are six rRNA operons and 69 tRNAs. A more exhaustive analysis of the drug-resistance determinants harbored by the A144 strain and their contexts and locations will be included in a future publication. The possibility of analyzing the complete genome sequence of this strain could shed more light on the knowledge of this important nosocomial pathogen. These results expand our understanding of the global public health problem caused by this pathogen and also allow us to compare the genome content of this strain isolated in an Argentinian hospital to those obtained in the rest of the world.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number JQSF00000000. The version described in this paper is version JQSF01000000.
  9 in total

1.  Transposons and integrons in colistin-resistant clones of Klebsiella pneumoniae and Acinetobacter baumannii with epidemic or sporadic behaviour.

Authors:  Sonia M Arduino; María Paula Quiroga; María Soledad Ramírez; Andrea Karina Merkier; Laura Errecalde; Ana Di Martino; Jorgelina Smayevsky; Sara Kaufman; Daniela Centrón
Journal:  J Med Microbiol       Date:  2012-06-21       Impact factor: 2.472

2.  Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype.

Authors:  Maria Soledad Ramirez; Mark D Adams; Robert A Bonomo; Daniela Centrón; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

3.  Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes.

Authors:  Eylem Sercan Özgür; Elif Sahin Horasan; Kerem Karaca; Gülden Ersöz; Sibel Naycı Atış; Ali Kaya
Journal:  Am J Infect Control       Date:  2014-02       Impact factor: 2.918

4.  Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases.

Authors:  M Catalano; L S Quelle; P E Jeric; A Di Martino; S M Maimone
Journal:  J Hosp Infect       Date:  1999-05       Impact factor: 3.926

5.  Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.

Authors:  Anis Chaari; Basma Mnif; Mabrouk Bahloul; Fouzia Mahjoubi; Kamilia Chtara; Olfa Turki; Nourhene Gharbi; Hedi Chelly; Adnene Hammami; Mounir Bouaziz
Journal:  Int J Infect Dis       Date:  2013-09-11       Impact factor: 3.623

6.  Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III.

Authors:  María Silvina Stietz; María Soledad Ramírez; Elisabet Vilacoba; Adriana Karina Merkier; Adriana Sara Limansky; Daniela Centrón; Mariana Catalano
Journal:  Infect Genet Evol       Date:  2013-01-08       Impact factor: 3.342

Review 7.  Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.

Authors:  Rémy A Bonnin; Patrice Nordmann; Laurent Poirel
Journal:  Expert Rev Anti Infect Ther       Date:  2013-06       Impact factor: 5.091

8.  Draft Genome Sequence of an Extensively Drug-Resistant Acinetobacter baumannii Indigo-Pigmented Strain.

Authors:  German Traglia; Elisabet Vilacoba; Marisa Almuzara; Leticia Diana; Andres Iriarte; Daniela Centrón; María Soledad Ramírez
Journal:  Genome Announc       Date:  2014-11-13

9.  Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.

Authors:  Mehrdad Behnia; Sharon C Logan; Linda Fallen; Philip Catalano
Journal:  BMC Res Notes       Date:  2014-04-11
  9 in total
  4 in total

1.  Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.

Authors:  Jesus Magallon; Kevin Chiem; Tung Tran; Maria S Ramirez; Veronica Jimenez; Marcelo E Tolmasky
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

2.  Aminoglycoside 6'-N-acetyltransferase Type Ib [AAC(6')-Ib]-Mediated Aminoglycoside Resistance: Phenotypic Conversion to Susceptibility by Silver Ions.

Authors:  Craig M Reeves; Jesus Magallon; Kenneth Rocha; Tung Tran; Kimberly Phan; Peter Vu; Yang Yi; Crista L Oakley-Havens; José Cedano; Verónica Jimenez; Maria S Ramirez; Marcelo E Tolmasky
Journal:  Antibiotics (Basel)       Date:  2020-12-31

3.  Amikacin potentiator activity of zinc complexed to a pyrithione derivative with enhanced solubility.

Authors:  Jesus Magallon; Peter Vu; Craig Reeves; Stella Kwan; Kimberly Phan; Crista L Oakley-Havens; Kenneth Rocha; Veronica Jimenez; María Soledad Ramirez; Marcelo E Tolmasky
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

Review 4.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.